Merit Medical Shareholders Elect Silvia M. Perez as New Director
16 Maggio 2024 - 10:05PM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of
healthcare technology, today announced that its shareholders
elected Silvia M. Perez, President of the Commercial Branding
and Transportation Division at 3M Company, as a director in Merit’s
Annual Meeting of Shareholders held on May 15, 2024. Merit’s
shareholders also re-elected Fred P. Lampropoulos and Stephen C.
Evans as directors. Ms. Perez and Messrs. Lampropoulos and Evans
were elected to serve three-year terms.
"We are pleased to welcome Silvia Perez as our newest
director,” said Mr. Lampropoulos, Merit’s Chairman and Chief
Executive Officer. “Her expertise and proven track record of
leadership success will provide valuable industry and
organizational perspective to both the board and the company’s
management team as we pursue our continued growth
initiatives.”
“I'm honored to join the Merit Board of Directors,” Perez said.
“I believe in the company's mission to improve and save lives
around the globe. I'm excited to bring my experience to the team as
they propel this mission forward."
Ms. Perez has worked for more than two decades in the healthcare
industry, with accomplishments in clinical, regulatory, operations,
marketing, and business leadership.
She joined 3M Company in 1994 and has held a variety of
leadership roles across the organization, both domestic and
international. Roles include President of Commercial Solutions
Division and Vice President of Acelity, Inc., which was the largest
acquisition in the history of 3M Company.
Ms. Perez holds a pharmaceutical chemist degree from the
University of the Republic (Uruguay), and is an industrial
pharmacist educated at the Federal University of Parana (Brazil).
She holds Six Sigma Black Belt and Master Black Belt
certifications.
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc.
is engaged in the development, manufacture, and distribution of
proprietary disposable medical devices used in interventional,
diagnostic, and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care, and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling more than 700 individuals.
Merit employs approximately 7,000 people worldwide.
TRADEMARKS Unless noted otherwise, trademarks and registered
trademarks used in this release are the property of Merit Medical
Systems, Inc., its subsidiaries, or its licensors.
CONTACTS PR/Media Inquiries Sarah Comstock Merit
Medical +1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIES Mike Piccinino, CFA, IRC Westwicke
- ICR +1-443-213-0509 | mike.piccinino@westwicke.com
Grafico Azioni Merit Medical Systems (NASDAQ:MMSI)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Merit Medical Systems (NASDAQ:MMSI)
Storico
Da Feb 2024 a Feb 2025